Home » Oculus Secures FDA Clearance for Post-Dermal Device
Oculus Secures FDA Clearance for Post-Dermal Device
Petaluma, Calif.-based Oculus Innovative Sciences has received FDA 510(k) premarket clearance for the company’s post-dermal-procedures device.
The device is intended to remove foreign material and debris after dermal procedures.
Oculus plans to market the device in the U.S. in March 2017. — José Vasquez
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May